Indeed, among the patients with ERBB2/HER2-positive breast cancer, patients with the F/F158 genotype (46%) and F/V158 genotype (42%) have greater prevalence relative to those with the V/V158 genotype (12%). Here, ERBB2 is linked to breast carcinoma.